Posted byOrthoEx Posted in
Posted on Nov 28, 2017
Schlieren (Zurich), Switzerland, November 28, 2017

Kuros announced today that its Chief Medical Officer, Dr. Virginia Jamieson, has reached retirement age and will retire from full-time employment with effect as of May 31, 2018. Her succession will be announced in due course.

Dr. Joost de Bruijn, appointed CEO of Kuros Biosciences commented: “I would like to thank Dr. Jamieson for her many contributions and years of service as the Chief Medical Officer of Kuros. She successful designed and delivered clinical studies for the Neuroseal and PTH programs KUR-111, KUR-112 and KUR-113. Dr. Jamison will continue to drive clinical development and be actively engaged in identifying her successor.”